Belgium’s eTheRNA gets EU grant to develop mRNA cancer vaccinesBelgian immunotherapy firm eTheRNA has received a €6.9 million grant from the European Commission to accelerate clinical development Share XBelgium’s eTheRNA gets EU grant to develop mRNA cancer vaccineshttps://pharmaphorum.com/news/belgiums-etherna-gets-eu-grant-to-develop-mrna-cancer-vaccines/
